News and events
- All
- Events
- Press releases
- Publications
All
- All
- Events
- Press releases
- Publications
ExeVir Bio to Accelerate Development of New Treatment Conferring Broad Protection Against Covid-19
ExeVir Bio announces today a first closing of a EUR23 million Series A financing led by Fund+, with the participation of VIB, UCB Ventures, the ...
July 28, 2020
Read More
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Using llamas immunized with prefusionstabilized betacoronavirus spike proteins, Wrapp et al. identify neutralizing cross-reactive single-domain camelid antibodies, which may serve not only as useful reagents ...
July 24, 2020
Read More